Path to a Cure: Research Grants

Path to a Cure: Research Grants are intended to facilitate or enable the development of new information that may contribute to the development of new therapies focused upon repair or replacement of CFTR variants not served by existing small molecule modulators. Proposals must be hypothesis driven and contain sufficient preliminary data to justify support from the Cystic Fibrosis Foundation. However, proposals that aim to develop tools or reagents that are not typically hypothesis driven but may facilitate research that could lead to a cure will be considered through this mechanism. Information derived from such studies will hopefully lead to submission to other funding agencies, such as the National Institutes of Health (NIH).

Up to $450,000 USD over three years, plus an additional 12% of indirect costs.